CONNEXIN 43 EXPRESSION PREDICTS POOR PROGRESSION-FREE SURVIVAL IN PATIENTS WITH NON-MUSCLE INVASIVE UROTHELIAL BLADDER CANCER

被引：0
|
作者：
Poyet, Cedric
Buser, Lorenz
Roudnicky, Filip
Detmar, Michael
Hermanns, Thomas
Mannhard, Doris
Sulser, Tullio
Moch, Holger
Wild, Peter
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.2470
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP68-08
引用
收藏
页码：E860 / E861
页数：2
相关论文
共 50 条
  • [1] Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
    Poyet, Cedric
    Buser, Lorenz
    Roudnicky, Filip
    Detmar, Michael
    Hermanns, Thomas
    Mannhard, Doris
    Hoehn, Andrej
    Rueschoff, Jan
    Zhong, Qing
    Sulser, Tullio
    Moch, Holger
    Wild, Peter J.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (10) : 819 - 824
  • [2] Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder
    Kamel, Nahla Abdelfattah
    Abdelzaher, Eman
    Elgebaly, Omar
    Ibrahim, Shery Abdullah
    [J]. JOURNAL OF HISTOTECHNOLOGY, 2020, 43 (01) : 21 - 28
  • [3] T1 SUBSTAGE IN NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA CAN PREDICT PROGRESSION FREE SURVIVAL
    Chen, Yu-Kuang
    Lin, Tzu-Ping
    Chang, Yen-Hwa
    Kuo, Junne-Yih
    Chung, Hsiao-Jen
    Wu, Howard Hung-Hao
    Huang, Eric Yi-Hsiu
    Lin, Chih-Chieh
    Fan, Yu-Hua
    Huang, I-shen
    Lu, Shih-Yen
    Lin, Alex T. L.
    Huang, William J.
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1074 - E1075
  • [4] DISCONTINUANCE OF BCG IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER IS ASSOCIATED WITH LOWER PROGRESSION FREE SURVIVAL
    Minich, A.
    Sukonko, O. G.
    Krasny, S. A.
    Polyakov, S. L.
    Rolevich, A., I
    Vasilevich, V. Y.
    Mokhort, A. A.
    Zhegalik, A. G.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 544 - 544
  • [5] FOXM1 predicts disease progression in non-muscle invasive bladder cancer
    Sebastien Rinaldetti
    Ralph Wirtz
    Thomas Stefan Worst
    Arndt Hartmann
    Johannes Breyer
    Lars Dyrskjot
    Philipp Erben
    [J]. Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1701 - 1709
  • [6] FOXM1 predicts disease progression in non-muscle invasive bladder cancer
    Rinaldetti, Sebastien
    Wirtz, Ralph
    Worst, Thomas Stefan
    Hartmann, Arndt
    Breyer, Johannes
    Dyrskjot, Lars
    Erben, Philipp
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (09) : 1701 - 1709
  • [7] High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival
    Roudnicky, Filip
    Dieterich, Lothar C.
    Poyet, Cedric
    Buser, Lorenz
    Wild, Peter
    Tang, Dave
    Camenzind, Peter
    Ho, Chien Hsien
    Otto, Vivianne I.
    Detmar, Michael
    [J]. JOURNAL OF PATHOLOGY, 2017, 242 (02): : 193 - 205
  • [8] DIABETES MELLITUS PREDICTS POOR RESPONSE TO INDUCTION BCG IN NON-MUSCLE INVASIVE BLADDER CANCER
    Schade, George R.
    Parker, Walter R.
    He, Chang
    Beydoun, Celia
    Montgomery, Jeffrey S.
    Lee, Cheryl T.
    Weizer, Alon Z.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E520 - E520
  • [9] TUMOR STAGE ON RE-STAGING TRANSURETHRAL RESECTION PREDICTS RECURRENCE AND PROGRESSION FREE SURVIVAL OF PATIENTS WITH HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Bishr, Mohamed
    Latour, Mathieu
    Lattouf, Jean-Baptiste
    Saad, Fred
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E729 - E730
  • [10] Assessment of recurrence and progression risk in patients with non-muscle invasive bladder cancer
    Rolevich, A. I.
    Mirilenko, L. V.
    [J]. ONKOUROLOGIYA, 2016, 12 (04): : 119 - 130
12345